We are thrilled to share the updated Exceptional Reviewers List 2025. This program was designed to recognize scholars who have consistently delivered exceptional review reports to our journal. Committed to fostering rigorous research and promoting knowledge exchange, Cancers (ISSN: 2072-6694) recognizes the significant role that our reviewers play in maintaining the quality and integrity of the articles that we publish. According to surveys conducted in 2024, 92% of our authors rate the peer-review process as good or excellent, which is thanks to our pool of excellent reviewers.

We wish to express our sincere appreciation to all the reviewers who have generously volunteered their time and expertise to assist Cancers’ peer-review process. Their dedication and attention to detail in evaluating manuscripts, offering valuable feedback and contributing to academic rigor, are truly commendable.

The Exceptional Reviewers List was introduced in April 2025. Each quarter, we select a group of outstanding reviewers, and we introduce them here.

Q1
Name: Dr. Mohammad Mofatteh
Affiliation: School of Medicine, Dentistry and Biomedical Sciences, Queen’s University, Belfast, UK
Interests: neurosurgery; surgery; neuroscience; global health; medical education
“Engaging in peer-review sharpens my critical thinking, keeps me at the forefront of cutting-edge research, and strengthens the scientific community by ensuring rigorous quality assurance. I prioritize delivering constructive feedback to elevate the clarity, validity, and impact of each manuscript.”

Name: Dr. Radu O. Minea
Affiliation: Department of Neurosurgery, Keck School of Medicine, USC, Los Angeles, CA 90089, USA
Interests: cancer biology; apoptosis; cell culture; cell signaling; cancer cell biology; cell proliferation; flow cytometry; gene expression; immunohistochemistry; Western blot analysis
“I have enjoyed working with the editors of the Cancers journal in my past interactions with them and I am committed to help with the peer-review process in the future.”

Name: Dr. Radoslaw Pach
Affiliation: Jagiellonian University Medical College, Krakow, Poland
Interests: oncological surgery; colorectal cancer; gastric cancer; thyroid surgery; hernia; laparoscopy
“I review for journals using my clinical and research expertise to assess oncology studies, focusing on rigor, clarity, and impact, and providing constructive, evidence-based feedback.”

Name: Dr. Giovanni Colonna
Affiliation: Medical Informatics Unit, AOU L. Vanvitelli, University of Campania, Piazzetta Sant’Aniello a Caponapoli 2, 80138 Naples, Italy
Interests: cancer biology; bioinformatics and computational biology; enzymes; proteins; PCR;
protein purification; protein expression; evolution; critical thinking; cancer cell biology
“Cancer research faces significant obstacles in accurately modeling the complexity of human tumors with current preclinical systems. From observational data, we cannot directly obtain the deep molecular causes without specific experimental data.”

Name: Prof. Dr. Lars Martin Wagner
Affiliation: Division of Pediatric Hematology/Oncology, Duke University, Durham, North Carolina
Interests: pediatric sarcoma; young adult sarcoma; clinical trials; sarcoma biology; treatment response; rare cancers; translational research

Q2
Name: Dr. Yuki Arita
Affiliation: Memorial Sloan-Kettering Cancer Center, New York, United States
Interests: bladder urothelial carcinoma; prostate cancer; renal cell carcinoma; bladder cancer; rectal cancer; magnetic resonance machine learning deep learning medical imaging physics
“It is a privilege to contribute to the advancement of scientific knowledge through constructive and timely peer review.”

Name:  Dr. Liviu Bilteanu
Affiliation: Department of Oncology at Institute of Oncology Bucharest, Carol Davila University of Medicine and Pharmacy, 37, Dionisie Lupu Street, 020021 Bucharest, Romania
Interests: oncology; colorectal; lung; breast; diet; microbioma; omics
“Reviewing for MDPI has been a rewarding and enriching experience. First of all, the MPDI review platform has a user-friendly interface, which simplifies the evaluation process. MDPI encourages scientific rigor and transparency, stimulating constructive and fair peer review to improve the submitted paper quality. I am also grateful for the recognition of reviewers’ efforts through discount vouchers for future publications and inclusion in MDPI’s annual acknowledgment of reviewers. Reviewing for MDPI is a real opportunity to stay up-to-date with the latest research in my field and to enhance my own knowledge and critical analysis skills.”

Name: Dr. Abdul Karim Ghaith
Affiliation: Johns Hopkins University, School of Medicine, Department of Neurosurgery, Baltimore, MD 21231, USA
Interests: machine learning, spine, brain, neurology, neurosurgery, neuroradiology, artificial intelligence, tumors
“Reviewing for Cancers has been a rewarding experience and an opportunity to critically engage with cutting-edge oncology research and help uphold scientific rigor and research integrity.”

Name:  Dr. Borek Sehnal
Affiliation: Department of Obstetrics and Gynaecology, University Hospital Kralovske Vinohrady and Third Faculty of Medicine, Charles University, Srobarova 1150/50, Prague 10, 100 34, Czech Republic
Interests: gynecology; ectopic pregnancy; women; quality of life; surgical terminations of pregnancy; ovarian hyperstimulation syndrome; cervical cancer screening

Name: Dr. Maureen E. Canavan
Affiliation: Yale Cancer Outcomes, Public Policy and Effectiveness Research (COPPER) Center, Yale University School of Medicine, New Haven, Connecticut, USA
Interests: non-small cell lung cancer; health management; end-of-life care